GLP-1 weight loss medication

Based on several clinical studies, GLP-1 medications can help you to lose up to 20% of your body weight in a year combined with diet and exercise.

• Clinical trials of Mounjaro (a GLP-1/GIP medication) show it can help you lose on average up to 20% of your body weight in one year.
• Clinical trials of Wegovy (a GLP-1 medication) in people without diabetes, show it can help you lose on average up to 15% of your body weight in one year.
• Clinical trials of Saxenda (a GLP-1 medication) in people without diabetes, show it can help you lose on average up to 9% of their body weight in 56 weeks.
• Clinical trials for Ozempic (a GLP-1 medication) in people with diabetes, show it can help you lose on average up to 7% in one year.

Our program offers GLP-1 injectable treatments, which are proven to be effective for sustainable weight loss.

GLP-1s are natural gut hormones that signal your brain to reduce appetite, enhance metabolism and improve digestion, which causes prolonged fullness and better nutrient absorption. The GLP-1 medications we offer are: Semaglutide with Glycine and B12, Ozempic®, Wegovy®, Saxenda®, and Mounjaro™, which is also a GIP receptor agonist.

All our medications are clinically validated and can support your weight loss journey. Your Levity clinical reviewer will determine the most suitable option for you.

The cost of medication, prescription, clinical consultation and shipping are all included in one monthly fee. This cost varies based on the medication you’re prescribed. It also includes follow-up appointments, coaching and any additional medication you may be offered to help reduce side effects.

We combine our prescription cost with the medication and service benefits into one total monthly cost. This varies based on the medication you choose from the treatments you’re eligible for. Typically, the total cost ranges from $225–$1,599 a month.

We don’t currently accept insurance, but we’re planning to in the future.

We currently supply the following states: Colorado, Florida, Georgia, Hawaii, Illinois, Iowa, Maine, Maryland, Massachusetts, Missouri, Montana, Nebraska, Nevada, New York, North Dakota, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Dakota, Tennessee, Texas, Virginia, Washington and Wyoming.

We’re adding more locations soon, so if you’re interested in our treatments contact us and we’ll do our best to reach you as soon as possible.

Our medications belong to a class of drugs known as GLP-1s, which are clinically tested, stimulant-free, and non-habit forming. Their most common side effects are gastrointestinal discomfort such as nausea, vomiting and diarrhea. These typically resolve over the first few weeks of treatment.

In the most recent clinical trials, less than 5% of people discontinued GLP-1 medications because of side effects. If you do experience any side effects, you can reach out to our clinical team directly for support.